Jacobs Levy Equity Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.81M | Sell |
|
|||||
|
2025
Q2 | $3.42M | Buy |
|
|||||
|
2025
Q1 | $2.08M | Buy |
|
|||||
|
2024
Q4 | $1.86M | Sell |
|
|||||
|
2024
Q3 | $2.79M | Sell |
|
|||||
|
2024
Q2 | $4.57M | Buy |
|
|||||
|
2024
Q1 | $793K | Buy |
|
|||||
|
2023
Q4 | $577K | Sell |
|
|||||
|
2023
Q3 | $3.33M | Sell |
|
|||||
|
2023
Q2 | $8.14M | Sell |
|
|||||
|
2023
Q1 | $17M | Buy |
|
|||||
|
2022
Q4 | $16.9M | Buy |
|
|||||
|
2022
Q3 | $5.25M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $359K | Buy |
|
|||||
|
2020
Q1 | $36K | Sell |
|
|||||
|
2019
Q4 | $7.3M | Buy |
|
|||||
|
2019
Q3 | $4.66M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $109K | Buy |
|